Your Hub for Alzheimer’s Diagnostic Resources and Best Practices
The timing and accuracy of an Alzheimer’s diagnosis is critical for patients. Fortunately, there are global advancements being made in the availability of diagnostic tests for Alzheimer’s — enabling a more simple, timely, and accurate diagnostic experience for patients.
Learn More About Available Diagnostic Tools and Assessments for Alzheimer’s
Understanding the Diagnostic Landscape is the First Step to Improving Care for Millions of Patients
Worldwide, approximately 55 million people are currently living with dementia, and about 60-80% of these cases can be attributed to Alzheimer's disease.
The timing and accuracy of diagnosis is critical for patients to ensure that individuals and their loved ones can learn more about the disease, make informed decisions on care and treatment, make healthy lifestyle changes, and improve overall quality of life.
As new diagnostic tools are being developed, it is critical to have consensus around how well tests should perform and in what situations they can be used. CEOi has been driving these efforts with worldwide experts to answer these questions and provide additional educational resources.
Read the Latest Diagnostic News and Insights
news web part will go here
Read the Latest
Diagnostic News and Insights
View More News & Insights Here
FDA Grants Breakthrough Device Designation to pTau 217 Blood Test for Alzheimer Disease
Go To Resource
The Global CEO Initiative on Alzheimer’s Disease
CEOi, founded in 2013, is an organization of private-sector leaders who have joined together to provide business leadership in the fight against Alzheimer’s. CEOi believes that, during this era of aging populations, it will take visionary, coordinated, goal-oriented leadership of public and private leaders working together to solve our greatest challenges. It is convened by UsAgainstAlzheimer’s.
